Title of Collaborative Activity: |
Influenza Vaccine Manufacturing Improvement Initiative |
Description of Collaborative Activity: |
Influenza Vaccine Manufacturing Improvement Initiative is a research-based HHS interagency collaborative program with industry to 1) optimize influenza virus vaccine strains for production yield and 2) develop faster potency and sterility assays. |
Type of Collaborative Activity: |
Other
|
Year the Collaborative Activity Originated: |
2010 |
NIH Participating Institutes/Centers/Office of the Director: |
NIAID |
HHS Agency Collaborators on this Activity: |
CDC, FDA |
